Jeffrey Stavenhagen

Company: Dianthus Therapeutics

Job title: Chief Scientific Officer

Seminars:

From Bench to Bedside: Streamlining Preclinical Strategies for Effective Complement Drug Development Across Disease Indications 12:30 pm

A comprehensive guide to improving the efficacy measurement and translational success of complement inhibitors. Explore cutting-edge methodologies and best practices in preclinical research to bridge the gap between laboratory findings and clinical application. Conduct detailed dose-response studies to determine the optimal dosing regimen that maximizes efficacy while minimizing toxicity Perform extensive safety and toxicology studies…Read more

day: Pre-Conference Workshop Day